Trump’s Pharma Tariffs Would Spare Richest Drugmakers While Punishing Some Small Ones

Health
By Rebecca Robbins from NYT Health https://ift.tt/kXwq6rH
via IFTTT International Trade and World Market, Drugs (Pharmaceuticals), United States Politics and Government, Prices (Fares, Fees and Rates), Factories and Manufacturing, Biotechnology and Bioengineering Big companies like Novartis say new tariffs won’t hit them. “A win for Pharma,” Wall Street analysts said.

Comments

Popular posts from this blog

Should the Autism Spectrum Be Split Apart?

The Jarring Contradiction at the Heart of Kennedy’s Agenda